In Veritas Medical Diagnostics Company Description
In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications.
Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke.
The company’s other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a noninvasive alternative to 2D X-ray scanning; osteoporosis detection and monitoring device, an instant display of bonemineral density for osteoporosis patients; and hand held digital strip reader for immunoassay applications.
It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005.
The company is based in Inverness, the United Kingdom.
| Country | United States |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 8 |
| CEO | G. Cooper |
Contact Details
Address: The Green House Inverness, Colorado IV2 3Bl United Kingdom | |
| Phone | 44 14 6366 7347 |
Stock Details
| Ticker Symbol | IVME |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | August - July |
| Reporting Currency | USD |
| ISIN Number | US45325A1007 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| G. T. Cooper | Chairman, Chief Executive Officer and President |
| Martin Edward Thorp | Chief Financial Officer, Principal Accounting Officer and Director |
| Robert Galvin | Head of Administration and Financial Controller |